Since there was no CN gain or loss predicted, studies to elucidate the genuine CNV status of ARMS2/HTRA1 in AMD patients, and its possible effect on ARMS2/HTRA1 expression would be needed. The gene discussed is HTRA1; the disease is age-related macular degeneration.